TargetMol
TargetMol Chemicals Inc., headquartered in Boston, Massachusetts, is a global supplier specializing in high-quality products and services for chemical and biological research. The company has grown into one of the world’s leading providers of small molecules and compound libraries, supporting academic, pharmaceutical, and biotech research worldwide.
TargetMol offers an extensive portfolio including 800+ compound libraries, 20,000+ inhibitors and agonists, 16,000+ natural products, 13,000+ recombinant proteins, as well as a broad range of reagent kits. These products are designed to support target identification, pathway analysis, and mechanism-of-action studies across diverse research fields.
The company’s solutions address key application areas such as oncology research, including target validation, pathway modulation, and therapeutic discovery; neurobiology, with a focus on neuronal signaling, neurodegeneration, and CNS-related targets; and immunology and inflammation, covering immune regulation, cytokine signaling, and inflammatory diseases. TargetMol also supports metabolic and endocrine research, as well as translational and preclinical development, enabling early-stage drug discovery, in vivo validation, and therapeutic development.
With a strong emphasis on diversity, quality, and research relevance, TargetMol is a trusted partner for modern drug discovery and life science research.
